Biomatter Series A: $18M

Nov 12, 2026Public sources — Collected from public sources, not yet cross-checked.

Biomatter raised $18 million in a series a round led by Astanor, announced Nov. 12.

Facts

Company: Biomatter
Amount: $18 million
Currency: USD
Stage: Series A
Announced: Nov 12, 2026
Instrument: Equity

Investors

Led by: Astanor
Participants: UVC Partners Inventure Partners Metaplanet

Use of funds

Establishing a new 2,000-square-metre enzyme design and testing facility in Vilnius, expanding the commercial team and United States presence, and developing its computational platform.

As stated by the company.

Sources

1.Biomatter lands $18M to speed up enzyme development with AI — Tech.eu, Nov 12, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Nov 12, 2026